Similares a Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD

20 vecinos (text_768) · 88 views · HCPLive · Estados Unidos


★	Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD	HCPLive @hcplivenews	88	Estados Unidos
15	How to Inject Zepbound: Step-by-Step Guide on How to Use Zepbound Pen	Way Less Weight Loss Clinic @waylessclinic	32.4K	—	85
16	How to Inject Tirzepatide: Step-by-Step Weight Loss Pen Injection Guide for Beginners	Way Less Weight Loss Clinic @waylessclinic	16.3K	—	85
12	The Anti Inflammation Benefit #glp1 #semaglutide #tirzepatide #microdosing #weightlossmedication	Dr. G's Lifestyle Medicine Network @gooddrg	5.7K	Estados Unidos	85
20	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	85
3	Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential	HCPLive @hcplivenews	839	Estados Unidos	85
5	Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss	HCPLive @hcplivenews	533	Estados Unidos	85
17	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	85
8	3 things you need to know about Tirzepatide for weight loss.	MurgaSkin Labs @murgaskinlabs	317	—	85
2	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss	HCPLive @hcplivenews	250	Estados Unidos	86
4	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	85
18	SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo	HCPLive @hcplivenews	174	Estados Unidos	85
9	Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3	HCPLive @hcplivenews	158	Estados Unidos	85
19	How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD	HCPLive @hcplivenews	109	Estados Unidos	85
11	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	85
7	What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis?	HCPLive @hcplivenews	92	Estados Unidos	85
10	What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis?	HCPLive @hcplivenews	91	Estados Unidos	85
14	ZUPREME-1: Petrelintide Reduces Obesity, Maintains Tolerability in Phase 2 Trial	HCPLive @hcplivenews	81	Estados Unidos	85
13	Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients \| ATS 2026	HCPLive @hcplivenews	68	Estados Unidos	85
1	Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA	HCPLive @hcplivenews	30	Estados Unidos	87
6	Structuring Obesity Trials to Optimize Patient Retention and Data Integrity	HCPLive @hcplivenews	18	Estados Unidos	85